Magnesium and Ferriprox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnesium (magnesium) and Ferriprox (deferiprone). Common drug interactions include gait disturbance among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Magnesium and Ferriprox. It is created by eHealthMe based on reports of 73 people who take the same drugs from the FDA, and is updated regularly.

What is Magnesium?

Magnesium has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 121,144 Magnesium users. Check the latest studies of Magnesium.

What is Ferriprox?

Ferriprox has active ingredients of deferiprone. eHealthMe is studying from 1,991 Ferriprox users. Check the latest studies of Ferriprox.



On Jul, 26, 2026

73 people who take Magnesium and Ferriprox together, and have interactions are studied.

Magnesium and Ferriprox drug interactions.

What are the common drug interactions of Magnesium and Ferriprox, by gender? *:

female:

  1. Gait disturbance
  2. Ill-defined disorder
  3. Klebsiella test positive
  4. Muscle fatigue (a condition in which muscles cannot exert their normal force)
  5. Muscular weakness (muscle weakness)
  6. Tibia fracture (fracture of lower leg bone)
  7. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  8. Weight decreased
  9. Death
  10. Urinary tract infection

male:

  1. Death
  2. Haemoglobin decreased
  3. Urinary tract infection
  4. Lung disorder (lung disease)
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Red blood cell count decreased
  8. Headache (pain in head)
  9. Oropharyngeal pain
  10. Dehydration (dryness resulting from the removal of water)

What are the common drug interactions of Magnesium and Ferriprox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Overdose
  2. Disease progression

10-19:

n/a

20-29:

  1. Fatigue (feeling of tiredness)
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting
  4. Iron binding capacity total decreased
  5. Iron binding capacity unsaturated decreased
  6. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  7. Transferrin saturation increased

30-39:

  1. Ill-defined disorder
  2. Death
  3. Food poisoning (poison in food)
  4. Gastric disorder (disease of stomach)
  5. Vomiting
  6. Abdominal discomfort
  7. Dyspnoea (difficult or laboured respiration)
  8. Fall
  9. Fibula fracture
  10. Klebsiella test positive

40-49:

  1. Headache (pain in head)
  2. Abdominal discomfort
  3. Muscle spasms (muscle contraction)
  4. Arthralgia (joint pain)
  5. Back pain
  6. Dizziness
  7. Syncope (loss of consciousness with an inability to maintain postural tone)

50-59:

  1. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  2. Hepatorenal syndrome (renal failure in patients with advanced chronic liver disease)
  3. Ill-defined disorder
  4. Death
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Road traffic accident
  8. Upper limb fracture
  9. Weight decreased

60+:

  1. Death
  2. Urinary tract infection
  3. White blood cell count increased
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Asthenia (weakness)
  6. Dyspnoea (difficult or laboured respiration)
  7. Fall
  8. Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts)
  9. Dehydration (dryness resulting from the removal of water)
  10. Diarrhoea

What are the existing conditions these people have? *

  1. Haemochromatosis (body to absorb more iron than usual from food): 38 people, 52.05%
  2. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 14 people, 19.18%
  3. Iron Metabolism Disorder: 7 people, 9.59%
  4. Anaemia (lack of blood): 7 people, 9.59%
  5. Subarachnoid Haemorrhage (blood leaks into the space between two membranes that surround the brain): 4 people, 5.48%
  6. Cerebrovascular Disorder (disease of brain): 4 people, 5.48%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium and Ferriprox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Magnesium and Ferriprox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Magnesium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ferriprox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Magnesium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ferriprox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on magnesium and deferiprone (the active ingredients of Magnesium and Ferriprox, respectively), and Magnesium and Ferriprox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: